Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 0 1 8 41
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 0 0 0 2 7 20
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 1 3 14
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 2 22
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 7 15
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 0 0 9 42
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 0 0 4 420
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 1 13 31
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 0 11 24
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 0 1 17 40
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 1 7 14
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 6 34
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 48 0 1 14 105
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 4 9
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 16 0 1 8 126
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 0 0 7 15
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 1 3 11 29
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 1 1 13 59
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 0 7 0 2 8 28
Total Working Papers 0 0 0 71 2 15 159 1,088


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 1 3 47 2 4 38 206
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 1 1 3 11 1 2 21 75
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 24 0 0 21 120
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 8 1 1 18 55
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 1 1 3 11 4 5 18 52
Total Journal Articles 2 3 9 101 8 12 116 508


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 14 1 2 17 104
Total Chapters 0 0 0 14 1 2 17 104


Statistics updated 2026-10-11